Johnson and Johnson Merck Consumer Pharmaceuticals

Johnson and Johnson Merck Consumer Pharmaceuticals Newswire

Comprehensive Real-Time News Feed for Johnson and Johnson Merck Consumer Pharmaceuticals.

Results 1 - 20 of 2,581 in Johnson and Johnson Merck Consumer Pharmaceuticals

  1. Mesh surgery scandal: Top US lawyer who claims manufacturers knew...Read the original story w/Photo

    5 hrs ago | The Daily Record

    A TOP US lawyer is to give evidence to the Scottish Parliament claiming manufacturers knew the risks of mesh implants . Attorney Adam Slater , who has won millions of pounds for victims of mesh surgery, will make a key presentation by video link to the Scottish Parliament Petitions Committee on Tuesday.


  2. Tax net worth of wealthy freeloadersRead the original story w/Photo

    19 hrs ago | Daily Herald

    Republicans get upset at "freeloaders" who get food stamps and other government benefits. On the other side of the economic tables are those with inherited wealth.


  3. Liberia Ebola vaccine trial "challenging" as cases tumbleRead the original story w/Photo

    Yesterday | AlertNet

    We use cookies to ensure that we give you the best experience on our website. By continuing to browse our site, you are giving your consent for us to set cookies.


  4. Fight over contact lens pricing heads to Oregon LegislatureRead the original story w/Photo

    Yesterday |

    Johnson & Johnson, the largest maker of contact lenses in the country,is headquartered in New Brunswick, N.J. The firm and other major makers of contacts have adopted a new pricing strategy that critics say is hurting consumers. (AP Photo An Internet firm that sells contact lenses is trying to persuade Oregon legislators to stop manufacturers from setting a minimum price on their products.


  5. This Stock Could Become the Next Johnson & JohnsonRead the original story w/Photo

    Yesterday | The Motley Fool

    J&J's Tylenol and Band-Aid brands are household staples, its prescription drugs are among the most widely used on the planet, and its medical devices are common in hospital surgical rooms everywhere. But J&J wasn't always as big as it is today, and that suggests that investors may be well served by keeping an eye on these three companies that our Motley Fool contributors believe could be J&J's in the making.


  6. Sepp Blatter has been Fifa president since 1998. Photo: APRead the original story w/Photo

    Yesterday | South China Morning Post

    Admit it, we are living in the octo age. At a mere 84, Clint Eastwood directed and produced the current hit movie American Sniper as well as the film version of Jersey Boys .


  7. Avon at a DiscountRead the original story w/Photo

    Friday | HAPPI/Household & PP Industry

    Hindsight is 50/50....a 50% discount that is. Even though Avon's share price has risen 8% in the past couple of days on reports that the company is in talks with the private-equity firm TPG about a potential takeover, analysts and investors were left to wonder what might have been.


  8. Ebola drugs: A factfileRead the original story w/Photo

    Friday | PhysOrg Weblog

    There is no licensed vaccine or treatment for Ebola, which has killed more than 8,600 people in West Africa out of more than 21,700 infected since the start of 2014. US health authorities announced Thursday that a large-scale trial will start in hard-hit Liberia with the two leading candidate vaccines.


  9. Johnson & Johnson: 'Slightly Overvalued' Is No Reason To SellRead the original story w/Photo

    Friday | Seeking Alpha

    In a recent article another contributor offered the following headline: "Johnson & Johnson Is Slightly Overvalued, Time To Sell." As you might have guessed from my article's title, I would contend that this is a dangerous way to think about the investing world.


  10. Johnson & Johnson: No Real Earnings Growth Since 2007; And Don't Ignore Special ItemsRead the original story w/Photo

    Friday | Seeking Alpha

    But detailed analysis shows no real growth in either revenue or earnings over the last 6 to 8 years. JNJ has virtually stood still for this period.


  11. Stocks rally, euro falls after Europe unveils stimulus planRead the original story

    Friday | West Hawaii Today

    A plan to revive Europe's sagging economy rippled through the financial world on Thursday, setting off a rally in the stock market that wiped out its losses for the year. The pledge by the European Central Bank to spend 1.1 trillion euros on bonds knocked down government borrowing rates across Europe and drove the euro to its lowest level against the dollar in 11 years.


  12. Hitting FIFA where it hurtsRead the original story w/Photo

    Friday | World Soccer

    Three sponsors have told FIFA that they do not intend to renew their contracts with the scandal-hit world governing body. Castrol, Continental Tyres and Johnson & Johnson have confirmed they have not renewed their deals.


  13. Beleaguered FIFA says brand is not 'toxic' with sponsorsRead the original story w/Photo

    Friday | Globe and Mail

    FIFA have rejected suggestions that major sponsors were cutting their ties with the organization because it was a "toxic brand", saying on Friday that they were in advanced negotiations with new sponsors eager to replace the old. Britain's Daily Telegraph revealed on Friday that three major sponsors, Continental, Castrol and Johnson & Johnson, were not renewing their contracts with world soccer's governing body.


  14. Hidden Spy Camera Recorded Workers in Johnson & Johnson Bathroom: PoliceRead the original story w/Photo

    Friday |

    A designer at Johnson & Johnson discovered a pinhole camera hidden inside a unisex bathroom at the company's office at 601 W. 26th St. last week, according to police. The building's maintenance supervisor told police that the device was found on the wall above the light switch on Jan. 16, NYPD said.


  15. First GSK Ebola vaccine shipment due to arrive in LiberiaRead the original story

    Friday | WNFL-AM Green Bay

    The first batch of GlaxoSmithKline's experimental Ebola vaccine has been dispatched to West Africa and is expected to arrive in Liberia later on Friday, the British drugmaker said. The World Health Organization said on Thursday the Ebola outbreak in West Africa, the worst in history, appears to be waning but cautioned against complacency.


  16. 3 FIFA sponsors won't renew for 2018 World Cup in RussiaRead the original story w/Photo

    Friday | Korea Herald

    Three second-tier World Cup sponsors opting not to renew for the 2018 tournament in Russia was normal in sports business, FIFA insisted on Friday. Castrol, Continental and Johnson & Johnson all let their World Cup commercial deals expire in December amid widespread allegations of corruption implicating FIFA executive committee members.


  17. FIFA loses three more sponsorsRead the original story w/Photo

    Friday |

    According to reports from British media, FIFA - which receives approximately $1.5 billion in revenue from its sponsors every four years - lost the trio in the wake of Sony and Emirates' decision to cut ties with the international footballing body. German tire manufacturer Continental has had a sponsorship deal with FIFA since 2003.


  18. What They're Saying: Damian CollinsRead the original story

    Thursday Jan 22 | Soccer America

    "Fifa is a toxic brand. I think that's why companies who care about their reputation don't want to be associated with [it]."


  19. Lex Wagteveld Appointed to Lead Multisorb's Commercial Efforts in Northern EuropeRead the original story

    Wednesday Jan 21 | ThomasNet

    Buffalo, New York Multisorb Technologies announces the appointment of Mr. Alex Jan "Lex" Wagteveld to the position of Business Development Leader, Northern Europe - Healthcare Packaging as part of its latest step in global expansion. "Lex's appointment is part of our continuing drive to provide leadership in the global healthcare packaging market," said Adrian Possumato, Vice President of Healthcare Packaging.


  20. Investors Sold Johnson & Johnson For All the Wrong ReasonsRead the original story w/Photo

    Friday | The Motley Fool

    To put it mildly, Wall Street and investors weren't thrilled with the outcome, and its shares fell $2.75, or 2.6%. I know that may not sound like much, but when you're talking about one of the market's stalwart stocks, and also one of its least volatile, a move of this magnitude is likely to gain some attention.